Brand: ProteoGenix

Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade

PX-TA1289-100UG
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: IgG2, Kappa

$238.00

100ug + 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

SDS-PAGE for Demcizumab Biosimilar - Anti-DLL4 mAb

Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade

Product name	Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade
Source	CAS 1243262-17-0
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Demcizumab,OMP-21M18,DLL4 ,anti-DLL4
Reference	PX-TA1289
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG2-kappa
Clonality	Monoclonal Antibody

Product name	Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade
Source	CAS 1243262-17-0
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Demcizumab,OMP-21M18,DLL4 ,anti-DLL4
Reference	PX-TA1289
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG2-kappa
Clonality	Monoclonal Antibody

General information on Anti-DLL4 [Homo sapiens] (Demcizumab) Monoclonal Antibody

Demcizumab is investigated for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.

SDS-PAGE for Demcizumab Biosimilar - Anti-DLL4 mAb

Demcizumab Biosimilar - Anti-DLL4 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade

Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade

General information on Anti-DLL4 [Homo sapiens] (Demcizumab) Monoclonal Antibody

SDS-PAGE for Demcizumab Biosimilar - Anti-DLL4 mAb

Related products

Human DLL4 recombinant protein

Human IgG2 Isotype Control antibody (HyHEL-10)

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade

Specifications Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade

Description

General information on Anti-DLL4 [Homo sapiens] (Demcizumab) Monoclonal Antibody

Documents

QC & Validation

SDS-PAGE for Demcizumab Biosimilar - Anti-DLL4 mAb

Reviews

Related products

Human DLL4 recombinant protein

Human IgG2 Isotype Control antibody (HyHEL-10)

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade